Moderna Inc. Chief Executive Officer Stephane Bancel said he sees the pending launch of a planned flu vaccine as a chance to start a public conversation about how mRNA technology can offer better ...

Moderna gains fresh market attention after a unanimous flu vaccine panel vote strengthens confidence in its mRNA vaccine ...

The FDA's decision on the vaccine ‌is expected by August 5. Jefferies analyst Andrew Tsai does not expect flu revenue for Moderna until ​2027 and sees $750 million of U.S. flu and COVID-flu combo ...

Your resource for the hottest moving stocks and news. We cover all sectors and markets giving everyday investors access to ...

Moderna's mRNA flu vaccine could be approved by August, but federal policy and a nonfunctional advisory committee threaten ...

VRBPAC endorsed mRNA-1010 for adults 50-64 and ≥65 years, unanimously concluding benefits outweighed risks, supporting a late-stage regulatory path toward potential first mRNA seasonal influenza ...

A new kind of flu vaccine is moving a step closer to the U.S. market.

Moderna announced the appointment of Michael McDonnell to its Board of Directors, effective July 8, 2026. He will also join ...

Two of the companies are taking a second-go at FDA approval this summer, while another hopes to cement its leader-status in ...

CAMBRIDGE, MA / ACCESS Newswire / / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and ...